Elahere 100 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL9PZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,694
Award facts
- Contract value 100% obligated
- $16,694.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,694.24 for ELAHERE (mirvetuximab soravtansine) 100 mg/20 mL vials on December 1, 2025, with completion targeted for December 22, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under the company's larger prime contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. As one of the primary vendors in DLA's pharmaceutical supply chain, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The ELAHERE order fulfills specialized pharmaceutical needs within the company's extensive portfolio of brand-name and generic drugs, specialty medications, and medical supplies distributed across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FL9PZ?
SPE2DR26FL9PZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FL9PZ worth?
The government has obligated $16,694 on SPE2DR26FL9PZ.
Is contract SPE2DR26FL9PZ an order under another contract?
Yes. SPE2DR26FL9PZ is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL9PZ competed?
The extent of competition for SPE2DR26FL9PZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award